WO2025177244 - COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF PREPARING COMPOUNDS AND OF THEIR USE
National phase entry is expected:
Publication Number
WO/2025/177244
Publication Date
28.08.2025
International Application No.
PCT/IB2025/051910
International Filing Date
21.02.2025
Title **
[English]
COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF PREPARING COMPOUNDS AND OF THEIR USE
[French]
COMPOSÉS, COMPOSITIONS PHARMACEUTIQUES, PROCÉDÉS DE PRÉPARATION DES COMPOSÉS ET MÉTHODES D'UTILISATION DES COMPOSÉS
Applicants **
REPARE THERAPEUTICS INC.
Inventors
MOCHIRIAN, Philippe
Priority Data
63/556,512
22.02.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CIPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 7812 | |
| EPO | Filing, Examination, Granting | 164876 | |
| Japan | Filing, Examination, Granting | 5124 | |
| South Korea | Filing, Examination, Granting | 10610 | |
| USA | Filing, Examination, Granting | 36590 |
Total:
225,012
Contact Us
Abstract[English]
Disclosed are compounds and pharmaceutical compositions containing the same, methods of preparing the compounds, and methods of use. Compounds of the invention may be Polθ kinase inhibitors.[French]
L'invention concerne des composés, des compositions pharmaceutiques les contenant, des procédés de préparation des composés, et des méthodes d'utilisation. Les composés de l'invention peuvent être des inhibiteurs de la kinase Polθ.